ASK REDCHAT ANYTHING ABOUT IBIO INC.
iBio Inc. (NASDAQ: IBIO)
Listen to this Section
$1.81
-0.1250
(
-6.48% )
1.5M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| IBIO-200/202DetailsCOVID-19 |
Failed |
Market Data
|
| Open |
$1.81 |
| Previous Close |
$1.93 |
| Volume |
1.5M |
| Market Cap |
$91.41M |
| Day Range |
$1.80 - $2.08 |
| 52 Week Range |
$0.56 - $3.82 |
| Shares Outstanding |
49.68M |
| Change % |
-6.48% |
| Net Change |
▼ -0.1250 |
| Insider Ownership |
0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2008 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-240,858.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-01-13 |
Buy |
1838.00 |
Clark William D |
| 2025-01-13 |
Buy |
9191.00 |
Sender Gary |
| 2025-01-13 |
Buy |
183823.00 |
Parada Antonio Bernardino Guimaraes |
| 2025-01-13 |
Buy |
9191.00 |
Brenner Martin |
| 2025-01-13 |
Buy |
9191.00 |
Banjak Marc |
| 2025-01-13 |
Buy |
18382.00 |
Arkowitz David |
| 2024-05-13 |
Sale |
-90000.00 |
Duran Felipe |
| 2024-05-13 |
Sale |
-147300.00 |
Brenner Martin |
| 2024-04-26 |
Sale |
-35800.00 |
Duran Felipe |
| 2023-11-03 |
Sale |
-4881.00 |
Brenner Martin |